As of 9:30 AM on the 8th, Celltrion Healthcare is trading at 155,700 KRW, up 0.65% from the previous day. This is a decline of 11.98% compared to December 21. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.

Over the past five days, individual investors have net purchased 774,823 shares, while foreigners and institutions have net sold 248,142 shares and 538,118 shares, respectively.



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing